13F

Stock

Crispr Therapeutics Ag

CRSP · held by 2 managers

Reported value

$17.1M

Holders

2

+0 new · −0 exited

Holders’ est. mark

$1.7M

Price effect on 2 books still in the name

Largest holder

$16.4M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC361.8K$16.4M$1.66MAdded$522K
Marex Group plc16.9K$763.8K$45.1KAdded$363.4K

Positions as of Q1 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.